2025-523469-79-00RecruitingPhase 1
A Study to Investigate ARV-027 in Healthy Male Participants and Participants with Spinal and Bulbar Muscular Atrophy
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Jul 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- Jan 2026
- Lead sponsor
- Arvinas Operations Inc.
- EU CT number
- 2025-523469-79-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 106
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult men: healthy volunteers and men with spinal and bulbar muscular atrophy.
- Age
- 18 years or older
- Sex
- Men only
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.